LifeVantage's new MindBody GLP-1 System is riding the coattails of GLP-1 weight loss drugs. See why I rate LFVN stock as a ...
Research showed that patients who lose weight on GLP-1 agonists frequently experience muscle mass loss. Obesity experts share ...
With three meds approved for weight management and several on the way, these may make a dent in the obesity epidemic.
JPMorgan's annual survey of 40 executives shows that coverage of popular weight-loss drugs continues to slowly increase ...
GLP-1 weight loss users cut food spending in their first 3 months, says Circana. But by the end of year one, spending is ...
British fund manager Terry Smith has sold his stake in Diageo Plc, citing concerns about the management of the drinks company ...
Guidepoint Qsight, a leader in leveraging proprietary data to provide unmatched analytics solutions, today revealed new ...
Over her three-decade career, weight management physician Dr. Sarah Ro has seen hundreds of patients. Many of them are on ...
Ozempic, Wegovy and Mounjaro, all GLP-1 anti-obesity medications, may offer health benefits beyond weight loss. Studies show ...
Weight management platform Found is today launching oral semaglutide dissolvable tablets for individuals looking for ...
Metsera has linked its GLP-1 drug candidate to weight loss of up to 11.3% after 12 weeks, encouraging the biotech to use some ...